118 related articles for article (PubMed ID: 10212389)
1. Dicarba-closo-dodecaboranes as a pharmacophore. Retinoidal antagonists and potential agonists.
Iijima T; Endo Y; Tsuji M; Kawachi E; Kagechika H; Shudo K
Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):398-404. PubMed ID: 10212389
[TBL] [Abstract][Full Text] [Related]
2. Dicarba-closo-dodecaboranes as a pharmacophore. Novel potent retinoidal agonists.
Endo Y; Iijima T; Kagechika H; Ohta K; Kawachi E; Shudo K
Chem Pharm Bull (Tokyo); 1999 Apr; 47(4):585-7. PubMed ID: 10319433
[TBL] [Abstract][Full Text] [Related]
3. Structure-Activity study of retinoid agonists bearing substituted dicarba-closo-dodecaborane. Relation between retinoidal activity and conformation of two aromatic nuclei.
Endo Y; Iijima T; Yaguchi K; Kawachi E; Inoue N; Kagechika H; Kubo A; Itai A
Bioorg Med Chem Lett; 2001 May; 11(10):1307-11. PubMed ID: 11392543
[TBL] [Abstract][Full Text] [Related]
4. Polyenylidene thiazolidinedione derivatives with retinoidal activities.
Tashima T; Kagechika H; Tsuji M; Fukasawa H; Kawachi E; Hashimoto Y; Shudo K
Chem Pharm Bull (Tokyo); 1997 Nov; 45(11):1805-13. PubMed ID: 9396157
[TBL] [Abstract][Full Text] [Related]
5. Estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.
Endo Y; Yoshimi T; Iijima T; Yamakoshi Y
Bioorg Med Chem Lett; 1999 Dec; 9(24):3387-92. PubMed ID: 10617077
[TBL] [Abstract][Full Text] [Related]
6. Novel retinoid X receptor (RXR) antagonists having a dicarba-closo-dodecaborane as a hydrophobic moiety.
Ohta K; Iijima T; Kawachi E; Kagechika H; Endo Y
Bioorg Med Chem Lett; 2004 Dec; 14(23):5913-8. PubMed ID: 15501068
[TBL] [Abstract][Full Text] [Related]
7. New estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.
Endo Y; Yoshimi T; Yamakoshi Y
Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):312-4. PubMed ID: 10705532
[TBL] [Abstract][Full Text] [Related]
8. Polymethylcarborane as a novel bioactive moiety: derivatives with potent retinoid antagonistic activity.
Endo Y; Yaguchi K; Kawachi E; Kagechika H
Bioorg Med Chem Lett; 2000 Aug; 10(15):1733-6. PubMed ID: 10937735
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity study of estrogenic agonists bearing dicarba-closo-dodecaborane. Effect of geometry and separation distance of hydroxyl groups at the ends of molecules.
Endo Y; Iijima T; Amakoshi Y; Kubo A; Itai A
Bioorg Med Chem Lett; 1999 Dec; 9(23):3313-8. PubMed ID: 10612591
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of retinoids with novel bulky hydrophobic partial structures.
Amano Y; Noguchi M; Nakagomi M; Muratake H; Fukasawa H; Shudo K
Bioorg Med Chem; 2013 Jul; 21(14):4342-50. PubMed ID: 23685180
[TBL] [Abstract][Full Text] [Related]
11. Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.
Umemiya H; Fukasawa H; Ebisawa M; Eyrolles L; Kawachi E; Eisenmann G; Gronemeyer H; Hashimoto Y; Shudo K; Kagechika H
J Med Chem; 1997 Dec; 40(26):4222-34. PubMed ID: 9435893
[TBL] [Abstract][Full Text] [Related]
12. Novel iodinated carboranes: synthesis of the 8-iodo-7,9-dicarba-nido-undecaborate anion and 2-iodo-1,7-dicarba-closo-dodecaborane.
Safronov AV; Kabytaev KZ; Jalisatgi SS; Hawthorne MF
Dalton Trans; 2014 Sep; 43(33):12467-9. PubMed ID: 24782077
[TBL] [Abstract][Full Text] [Related]
13. Novel retinoidal tropolone derivatives. Bioisosteric relationship of tropolone ring with benzoic acid moiety in retinoid structure.
Ebisawa M; Ohta K; Kawachi E; Fukasawa H; Hashimoto Y; Kagechika H
Chem Pharm Bull (Tokyo); 2001 Apr; 49(4):501-3. PubMed ID: 11310685
[TBL] [Abstract][Full Text] [Related]
14. Syntheses and structure-activity relationships of 5,6,7, 8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxaline derivatives with retinoic acid receptor alpha agonistic activity.
Kikuchi K; Hibi S; Yoshimura H; Tokuhara N; Tai K; Hida T; Yamauchi T; Nagai M
J Med Chem; 2000 Feb; 43(3):409-19. PubMed ID: 10669568
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C modulators bearing dicarba-CLOSO-dodecaborane as a hydrophobic pharmacophore.
Endo Y; Yoshimi T; Kimura K; Itai A
Bioorg Med Chem Lett; 1999 Sep; 9(17):2561-4. PubMed ID: 10498208
[TBL] [Abstract][Full Text] [Related]
16. Potent estrogen agonists based on carborane as a hydrophobic skeletal structure. A new medicinal application of boron clusters.
Endo Y; Iijima T; Yamakoshi Y; Fukasawa H; Miyaura C; Inada M; Kubo A; Itai A
Chem Biol; 2001 Apr; 8(4):341-55. PubMed ID: 11325590
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and 11C-Radiolabelling of 2-Carboranyl Benzothiazoles.
Gona KB; Thota JL; Baz Z; Gómez-Vallejo V; Llop J
Molecules; 2015 Apr; 20(5):7495-508. PubMed ID: 25915463
[TBL] [Abstract][Full Text] [Related]
18. Potent androgen antagonists based on carborane as a hydrophobic core structure.
Fujii S; Goto T; Ohta K; Hashimoto Y; Suzuki T; Ohta S; Endo Y
J Med Chem; 2005 Jul; 48(14):4654-62. PubMed ID: 16000001
[TBL] [Abstract][Full Text] [Related]
19. Utility of boron clusters for drug design. Hansch-fujita hydrophobic parameters pi of dicarba-closo-dodecaboranyl groups.
Yamamoto K; Endo Y
Bioorg Med Chem Lett; 2001 Sep; 11(17):2389-92. PubMed ID: 11527738
[TBL] [Abstract][Full Text] [Related]
20. Modulators of tumor necrosis factor alpha production bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.
Tsuji M; Koiso Y; Takahashi H; Hashimoto Y; Endo Y
Biol Pharm Bull; 2000 Apr; 23(4):513-6. PubMed ID: 10784439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
